Cost Analysis Related to Diagnosis, Treatment and Management of Cervical Cancer in Antigua and Barbuda
A Prevalence-Based Cost-of-Illness Study
Bibliographic Data
| ID | 15499751 |
|---|---|
| Authors | Andre A N Bovell (0000-0002-4714-7320, University of KwaZulu-Natal, corresponding author), Cebisile Ngcamphalala (0000-0003-2960-1558, University of KwaZulu-Natal), D C Abbott (Antigua State College), Dane Abbott (Obstetrics and Gynaecology Department, Sir Lester Bird Medical Centre, St. John’s 35301, Antigua and Barbuda), Jabulani Ncayiyana (0000-0002-2151-1251, University of KwaZulu-Natal), Themba G Ginindza (0000-0002-0993-8308, University of KwaZulu-Natal) |
| Year | 2024 |
| Volume | 21 |
| Issue | 12 |
| Pages | 1685-1685 |
| Publication date | 2024-12-18 |
| Peer Reviewed | Yes |
| Open Access | Yes |
| Type | ARTICLE |
| Venue | International Journal of Environmental Research and Public Health (JOURNAL) |
| Journal identifiers | ISSN: 1661-7827 • E-ISSN: 1660-4601 |
| Publisher | Multidisciplinary Digital Publishing Institute (PUBLISHER • CH) |
| DOI | 10.3390/ijerph21121685 |
| PMID | 39767524 |
| OpenAlex | W4405538187 |
| Language | EN |
| Citations received | 4 |
| References cited | 30 |
Cervical cancer remains a significant public health issue globally. In Antigua and Barbuda, cervical cancer is ranked among the top five most common cancers in terms of incidence and mortality among females. There is no evidence that the costs of diagnosing, treating, and managing this cancer have been studied before in Antigua and Barbuda. From the providers' perspective, this study aimed to estimate costs associated with cervical cancer in Antigua and Barbuda. The prevalence-based cost-of-illness methodology was used to assess patient data abstracted from four study sites for the period 2017-2021, and to derive the annual prevalence. Top-down and bottom-up costing approaches were used to estimate direct medical costs. Costs were computed using the 2021 price level and converted to United States Dollars (USD). Total annual direct medical costs of cervical cancer were estimated at USD 0.24 million (ranging between USD 0.19 million and USD 0.30 million). Major cost drivers were treatment (USD 112,863.76), post-treatment side-effects care (USD 67,406.57), and the diagnostic process (USD 26,238.58). The overall direct medical unit costs for managing a case were estimated at USD 115,822.09. Our study reflects the current estimates for managing cervical cancer and provides evidence to complement cervical cancer prevention and cost containment measures in Antigua and Barbuda
Activity-based costing · Business · Cancer · Cervical cancer · Cost driver · Economic growth · Environmental health · Health care · Incidence (geometry · Indirect costs · Public health · Total cost · Cervical Cancer and HPV Research · Global Cancer Incidence and Screening · Medicine · Nursing
Cost analysis of female breast cancer in Antigua and Barbuda
Analysis of the Direct Medical Costs of Colorectal Cancer in Antigua and Barbuda
Overall Observed Survival of Female Breast, Cervical, Colorectal, and Prostate Cancers in Antigua and Barbuda, 2017–2021
Investigating Drug Treatment Costs and Patient Characteristics of Female Breast, Cervical, Colorectal, and Prostate Cancers in Antigua and Barbuda
| Unique citing works | 4 |
|---|---|
| Citations per year | 4 |
| Citation span | 2025 - 2026 (2) |
| Citation velocity | current |
| Highly cited | No |
| Citation types | Neutral: 4 |